"How much influence do we actually have on whether we develop breast cancer,” one sobering article asked in the wake of stories about scientific advances a few weeks ago. Another piece drew attention to the disturbing statistic that breast cancer recurs in almost one in four patients."
" team of researchers at Case Western Reserve University School of Medicine, led by Dr. Mark W. Jackson, have developed a novel method to identify genes that, when overexpressed, make normal cells behave like cancer cells. Using this method, the Jackson laboratory has identified a new oncogene, which is a gene that contributes to the development of cancer, named FAM83B."
A new study shows that the lack of a certain gene occurs in almost 28 percent of human breast cancers, playing a role in some 60,000 breast cancer cases in the United States and 383,000 worldwide this year.
"When Nancy Brinker, founder of Susan G. Komen for the Cure, announced last week that she would step down as chief executive, along with the president and two board members, many leaders of the charity’s local affiliates breathed a sigh of relief."
"Researchers at Moffitt Cancer Center, working with colleagues in Sweden, the Netherlands and Puerto Rico, have validated a radiosensitivity molecular signature that can lead to better radiation therapy decisions for treating patients with breast cancer. "
Breast cancer is the most commonly diagnosed cancer among women in the U.S. besides skin cancer. About 1 in 8 U.S. women (approximately 12%) will develop invasive breast cancer over the course of her lifetime.
"But the comments reported overnight by the news media made by Brinker and statements issued by the organization still seemed to indicate a certain sense of denial, as if the (pink) elephant in the room -- the controversy over Planned Parenthood funding earlier in the year -- was not really related to the leadership changes."
A new method of delivering a commonly used breast cancer drug could result in considerably less time spent in hospital for some women undergoing breast cancer treatment, according to the results of a Phase 3 trial published Online First...